Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PET Expert Panel Scans Alzheimer’s National Coverage Options

This article was originally published in The Gray Sheet

Executive Summary

CMS is considering limiting reimbursement of FDG PET for Alzheimer's disease diagnosis to specific clinical trial participants, according to Coverage & Analysis Group Director Steve Phurrough, MD

You may also be interested in...



PET Alzheimer’s Coverage Faces Uphill Battle Following AHRQ Report

A second 1AHRQ tech assessment finding insufficient evidence for PET in diagnosing Alzheimer's disease casts further doubt that CMS will reverse its national non-coverage policy for the indication

PET Alzheimer’s Coverage Faces Uphill Battle Following AHRQ Report

A second 1AHRQ tech assessment finding insufficient evidence for PET in diagnosing Alzheimer's disease casts further doubt that CMS will reverse its national non-coverage policy for the indication

CMS Requests Advice On Potential PET For Alzheimer’s Operational Issues

CMS is seeking public input on the types of minimal services that should be performed and documented before a PET scan is ordered to diagnose Alzheimer's disease

Related Content

UsernamePublicRestriction

Register

MT020062

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel